An Phase I Study of YY001 in Patients With Advanced Solid Tumors

Conditions: Advanced Solid Tumor Interventions: Drug: YY001 Sponsors: Shanghai Yuyao Biotech Co., Ltd. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials